Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia

Schizophrenia Research

Volumn 102, Issue 1-3, 2008, Pages 283-294

  Burnet, P W J ^a   Hutchinson, L ^a   von Hesling, M ^a   Gilbert, E J ^a   Brandon, N J ^b   Rutter, A R ^b   Hutson, P H ^b   Harrison, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Antipsychotic; d amino acid oxidase; D serine; Glycine; mRNA; NMDA receptor; Transporter

Indexed keywords

ALANINE SERINE CYSTEIN TRANSPORTER 1; BRAIN PROTEIN; CARRIER PROTEIN; CLOZAPINE; DEXTRO SERINE; GLYCINE TRANSPORTER 1; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SNAT2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; HUMAN; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

AMINO ACID TRANSPORT SYSTEM A; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CEREBELLUM; CONTROL GROUPS; FEMALE; GENE EXPRESSION; GLUTAMATES; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEURONS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SCHIZOPHRENIA; SERINE; SYNAPSES;

EID: 46249094959     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.02.009     Document Type: Article

References (78)

1. Almond S.L., Fradley R.L., Armstrong E.J., Heavens E.J., Rutter A.R., Newman R.J., Chiu C.S., Konno R., Hutson P.H., and Brandon N.J. Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia. Mol. Cell. Neurosci. 32 3 (2006) 324-334
2. Abbott C., and Bustillo J. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr. Opin. Psychiatry 19 2 (2006) 135-139
3. Aragon C., and Lopez-Corcuera B. Structure, function and regulation of glycine neurotransporters. Eur. J. Pharmacol. 479 1-3 (2003) 249-262
4. Avila M.T., Weiler M.A., Lahti A.C., Tamminga C.A., and Thaker G.K. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. Am. J. Psychiatry 159 9 (2002) 1490-1496
5. Bak L.K., Schousboe A., and Waagpetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 98 3 (2006) 641-653
6. Bendikov I., Nadri C., Amar S., Panizzutti R., De Miranda J., Wolosker H., and Agam G. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr. Res. 90 1-3 (2007) 41-51
7. Berger A.J., Dieudonne S., and Ascher P. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J. Neurophysiol. 80 6 (1998) 3336-3340
8. Bergeron R., Meyer T.M., Coyle J.T., and Greene R.W. Modulation of N-methyl-d-aspartate receptor function by glycine transport. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15730-15734
9. Bernstein E.M., and Quick M.B. Regulation of γ-aminobutyric acid (GABA) transporters by extracellular GABA. J. Biol. Chem. 274 2 (1999) 889-895
10. Betz H., Gomeza J., Armsen W., Scholze P., and Eulenburg V. Glycine transporters: essential regulators of synaptic transmission. Biochem. Soc. Trans. 34 (2006) 55-58
11. Burnet P.W., Michelson D., Smith M.A., Gold P.W., and Sternberg E.M. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundance of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638 1-2 (1994) 311-324
12. Burnet P.W.J., Hutchinson L., von Hesling M., Gilbert E.-J., and Harrison P.J. An examination of glycine and D-serine transporter expression in schizophrenia. J. Psychopharmacol. 20 Suppl 5 (2006) A18
13. Chumakov I., Blumenfeld M., Guerrasimenko O., Cavarec L., Palicio M., Abderrahim H., Bouguleleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., et al. Genetic and physiologic data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
14. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 3 5 (1996) 241-253
15. Coyle J.T., and Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology 174 1 (2004) 32-38
16. Cubelos B., Giménez C., and Zafra F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb. Cortex 15 4 (2005) 448-459
17. Danysz W., and Parsons A.C. Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50 4 (1998) 597-664
18. Detera-Wadleigh S.D., and McMahon F.J. G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol. Psychiatry 60 2 (2006) 106-114
19. 7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr. Res. 57 1 (2002) 15-26
20. Eastwood S.L., Cairns N.J., and Harrison P.J. Synaptophysin gene expression in schizophrenia - investigation of synaptic pathology in the cerebral cortex. Br. J. Psychiatry 176 3 (2000) 236-242
21. Eastwood S.L., Burnet P.W.J., Gittins R., Baker K., and Harrison P.J. Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia. Synapse 42 2 (2001) 104-114
22. Eastwood S.L., Cotter D., and Harrison P.J. Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105 1 (2001) 221-229
23. Franchi-Gazzola R., Dall'Asta V., Sala R., Visigalli R., Bevilacqua E., Gaccioli F., Gazzola G.C., and Bussolati O. The role of the neutral amino acid transporter SNAT2 in cell volume regulation. Acta Physiol. 187 1-2 (2006) 273-283
24. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral d- and l-amino acids. J. Biol. Chem. 275 13 (2000) 9690-9698
25. Gabernet L., Pauly-Evers M., Schwerdel C., Lentz M., Bluethmann H., Vogt K., Alberati D., Mohler H., and Boison D. Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci. Lett. 373 1 (2005) 79-84
26. Gadea A., and López-Colomé A.M. Glial transporters for glutamate, glycine, and GABA: II. GABA transporters. J. Neurosci. Res. 63 6 (2001) 461-468
27. Gegelashvilli G., and Schousboe A. High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 52 1 (1997) 6-15
28. Goff D.C., and Coyle J.T. The emerging glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158 9 (2001) 1367-1377
29. Gonzales-Gonzales I.M., Cubelos B., Gimenez C., and Zafra F. Immunohistochemical localization of the amino acid SNAT2 in the rat brain. Neuroscience 130 1 (2005) 61-73
30. Guastella J., Brecha N., Weigmann C., Lester H.A., and Davidson N. Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc. Natl. Acad. Sci. U. S. A. 89 15 (1992) 7189-7193
31. Harrison P.J., and Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361 9355 (2003) 417-419
32. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 1 (2005) 40-68
33. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., and Iyo M. Decreased serum levels of D-serine in patients with schizophrenia - evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 60 6 (2003) 572-576
34. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naïve schizophrenic patients. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 5 (2005) 767-769
35. Hashimoto K., Sawa A., and Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 62 11 (2007) 1310-1316
36. Helboe L., Egebjerg J., Moller M., and Thomsen C. Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain. Eur. J. Neurosci. 18 8 (2003) 2227-2238
37. Javitt D.C. Glycine transport inhibitors and the treatment of schizophrenia. Biol. Psychiatry 63 1 (2008) 6-8
38. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 10 (1991) 1301-1308
39. Javitt D.C., Balla A., and Sershen H. A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes. Brain Res. 941 1-2 (2002) 146-149
40. Kapoor R., Lim K.S.Y., Cheng A., Garrick T., and Kapoor V. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kyneurenine aminotransferase-1 (KAT-1). Brain Res. 1106 (2006) 205-210
41. Kim K.-M., Kingsmore S.F., Han H., Yang-Feng T.L., Godinot N., Seldin M.F., Caron M.G., and Giros B. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in human and mouse genomes. Mol. Pharmacol. 45 4 (1994) 608-617
42. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., and Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169 3-4 (2003) 215-233
43. Kumashiro S., Hashimoto A., and Nishikawa T. Free D-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res. 681 1-2 (1995) 117-125
44. Law A.J., Hutchinson L.J., Burnet P.W., and Harrison P.J. Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J. Neurosci. Res. 76 3 (2004) 376-382
45. Lopez-Bayghen E., Espinoza-Rojo M., and Ortega A. Glutamate down-regulates GLAST expression through AMPA receptors in Bergmann glial cells. Mol. Brain Res. 115 1 (2003) 1-9
46. Mackenzie B., and Erickson J.D. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch. Eur. J. Phsyiol. 447 5 (2004) 784-795
47. Mandela P., and Ordway G.A. The norepinephrine transporter and its regulation. J. Neurochem. 97 2 (2006) 310-333
48. Martina M., Gorfinkel Y., Halman S., Lowe J.A., Periyalwar P., Schmidt C.J., and Bergeron R. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J. Physiol. 557 2 (2004) 489-500
49. Martina M., Turcotte M.-E.B., Halman S., Tsai G., Tiberi M., Coyle J.T., and Bergeron R. Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J. Physiol. 563 4 (2005) 777-793
50. Martineau M., Baux G., and Mothet J.-P. D-serine signalling in the brain: friend and foe. Trends Neurosci. 28 8 (2006) 481-491
51. Matsui T., Sekiguchi M., Hashimoto A., Tomita U., Nishikawa T., and Wada K. Functional comparison of D-serine and glycine in rodents - the effect on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65 1 (1995) 454-458
52. Matsuo H., Kanai Y., Tokunaga M., Nakata T., Chairoungdua A., Ishimine H., Tsukada S., Ooigawa H., Nawashiro H., Kobayashi Y., Fukuda J., and Endou H. High affinity d- and l-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci. Lett. 358 2 (2004) 123-126
53. Melone M., Varoqui H., Erickson J.D., and Conti F. Localization of the Na+-coupled neutral amino acid transporter 2 in the cerebral cortex. Neuroscience 140 1 (2006) 281-292
54. Millan M.J. N-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179 1 (2005) 30-53
55. Miller R.F. D-serine as a glial modulator of nerve cells. Glia 47 2 (2004) 275-283
56. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40 5 (2003) 881-884
57. Mothet J.-P., Parent A.T., Wolosker H., Brady Jr. R.O., Linden D.J., Ferris C.D., Rogawski M.A., and Snyder S.H. D-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 97 9 (2000) 4926-4931
58. +-dependent glutamate transporter activity. Neurochem. Int. 37 2-3 (2000) 147-162
59. Nagata Y., Konno R., Yasumura Y., and Akino T. Involvement of d-amino-acid oxidase in elimination of free d-amino acids in mice. Biochem. J. 257 1 (1989) 291-292
60. Nakauchi J., Matsuo H., Kim D.K., Goto A., Chairoungdua A., Cha S.H., Inatomi J., Shiokawa Y., Yamaguchi K., Saito I., Endou H., and Kanai Y. Cloning and characterization of a human brain Na+-independent transporter for small neutral amino acids that transports D-serine with high affinity. Neurosci. Lett. 287 3 (2000) 231-235
61. Olney J., and Farber N. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 12 (1995) 998-1007
62. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., and Oliet S.H.R. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125 4 (2006) 775-784
63. Ribeiro C.S., Reis M., Panizzutti R., de Miranda J., and Wolosker H. Glial transport of the neuromodulator D-serine. Brain Res. 929 2 (2002) 202-209
64. Rutter A.R., Fradley R.L., Garrett E.M., Chapman K.L., Lawrence J.M., Rosahl T.W., and Patel S. Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating D-serine reuptake in the mouse CNS. Eur. J. Neurosci. 25 6 (2007) 1757-1766
65. Schell M.J. The N-methyl-d-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Phil. Trans. Roy. Soc. London B: Biol. Sci. 359 (2004) 943-964
66. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50 (2001) 521-530
67. Smith K.E., Borden L.A., Hartig P.R., Branchek T., and Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8 5 (1992) 927-935
68. Sugawara M., Nakanishi T., Fei Y.-J., Huang W., Ganapathy M.E., Leibach F.H., and Ganapathy V. Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J. Biol. Chem. 275 22 (2000) 16473-16477
69. Thomson A.M., Walker V.E., and Flynn D.M. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature 338 6214 (1989) 422-424
70. Tsai G., Ralph-Williams R.J., Martina M., Bergeron R., Berger-Sweeney J., Dunham K.S., Jiang Z.C., Caine S.B., and Coyle J.T. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc. Natl. Acad. Sci. U. S. A. 101 22 (2004) 8485-8490
71. Verrall L., Walker M., Rawlins N., Bunzel I., Kew J.N.C., Harrison P.J., and Burnet P.W.J. d-amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur. J. Neurosci. 26 6 (2007) 1657-1669
72. Xie X.M., Dumas T., Tang L., Brennan T., Reeder T., Thomas W., Klein R.D., Flores J., O'Hara B.F., Heller H.C., and Franken P. Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res. 1052 2 (2005) 212-221
73. +/neutral amino acid cotransport. J. Biol. Chem. 275 30 (2000) 22790-22797
74. Yee B.K., Balic E., Singer P., Schwerdel C., Grampp T., Gabernet L., Knuesel I., Benke D., Feldon J., Mohler H., and Boison D. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J. Neurosci. 26 12 (2006) 3169-3181
75. Zafra F., Gomeza J., Olivares L., Aragon C., and Gimenez C. Regional distribution and developmental variation of the glycine transporters Glyt1 and Glyt2 in the rat CNS. Eur. J. Neurosci. 7 6 (1995) 1342-1352
76. Zafra F., Aragon C., Olivares L., Danbolt N.C., Gimenez C., and Storm-Mathisen J. Glycine transporters are differentially expressed among CNS cells. J. Neurosci. 15 5 (1995) 3952-3969
77. - dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signalling systems. Pharmacol. Ther. 92 1 (2001) 21-55
78. Zahniser N.R., and Sorkin A. Rapid regulation of the dopamine transporter: role in stimulant addiction?. Neuropharmacology 47 Suppl (2004) 80-91